Most recently, Auron Therapeutics raised $27.3M in its Early Stage VC (Dec 2024).
- ·The complete investor list: 15 names
- ·Watch Auron Therapeutics: the Monday email on marks, rounds and moves
Auron Therapeutics round by round
4 roundsHow much has Auron Therapeutics raised?
Auron Therapeutics has raised $90.7 million across 4 recorded rounds since 2018. The largest was a $660,000 debt round in Jun 2018; the most recent was a $27.3 million early-stage round in Dec 2024.
Auron Therapeutics has filed 5 Form Ds with the SEC since 2018, most recently in Dec 2024 ($13.4 million sold to 15 investors).
Auron Therapeutics investors
15 investors are on record for Auron Therapeutics, including Qiming Venture Partners USA, DCVC, Polaris Partners and Arkin Capital. By type, the record holds 6 venture capital firms, 1 family office and 1 asset manager. The early-stage round in Dec 2024 drew 16 investors.
15 investors have backed Auron Therapeutics.
Frequently asked about Auron Therapeutics
- How much has Auron Therapeutics raised?
- Auron Therapeutics has raised $90.7M in total across 4 recorded funding rounds.
- When was Auron Therapeutics's last funding round?
- Auron Therapeutics's most recent recorded round was Early Stage VC in Dec 2024, raising $27.3M.